Cargando…

The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19

Studies on severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1) suggest a protective effect of anti-A antibodies against viral cell entry that may hold relevance for SARS-CoV-2 infection. Therefore, we aimed to determine whether ABO blood groups are associated with different severities of CO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoiland, Ryan L., Fergusson, Nicholas A., Mitra, Anish R., Griesdale, Donald E. G., Devine, Dana V., Stukas, Sophie, Cooper, Jennifer, Thiara, Sonny, Foster, Denise, Chen, Luke Y. C., Lee, Agnes Y. Y., Conway, Edward M., Wellington, Cheryl L., Sekhon, Mypinder S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2020
Materias:	Clinical Trials and Observations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594392/ https://www.ncbi.nlm.nih.gov/pubmed/33057633 http://dx.doi.org/10.1182/bloodadvances.2020002623

Ejemplares similares

Quantification of Neurological Blood-Based Biomarkers in Critically Ill Patients With Coronavirus Disease 2019
por: Cooper, Jennifer, et al.
Publicado: (2020)

Brain Hypoxia Is Associated With Neuroglial Injury in Humans Post–Cardiac Arrest
por: Hoiland, Ryan L., et al.
Publicado: (2021)

Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome
por: Chen, Luke Y.C., et al.
Publicado: (2020)

Assessing the importance of interleukin-6 in COVID-19
por: Chen, Luke Y C, et al.
Publicado: (2021)

The Association of Inflammatory Cytokines in the Pulmonary Pathophysiology of Respiratory Failure in Critically Ill Patients With Coronavirus Disease 2019
por: Stukas, Sophie, et al.
Publicado: (2020)

Intraparenchymal Neuromonitoring of Cerebral Fat Embolism Syndrome
por: Hoiland, Ryan Leo, et al.
Publicado: (2021)

Reduced fixed dose tocilizumab 400 mg IV compared to weight-based dosing in critically ill patients with COVID-19: A before-after cohort study
por: Stukas, Sophie, et al.
Publicado: (2022)

Soluble interleukin-6 receptor in the COVID-19 cytokine storm syndrome
por: Chen, Luke Y.C., et al.
Publicado: (2021)

Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality
por: Leatherdale, Alexander, et al.
Publicado: (2022)

Reduced prevalence of SARS-CoV-2 infection in ABO blood group O
por: Barnkob, Mike Bogetofte, et al.
Publicado: (2020)

Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes
por: England, James T., et al.
Publicado: (2021)

Individualized perfusion targets in hypoxic ischemic brain injury after cardiac arrest
por: Sekhon, Mypinder S., et al.
Publicado: (2017)

Association of Respiratory Parameters at Venovenous Extracorporeal Membrane Oxygenation Liberation With Duration of Mechanical Ventilation and ICU Length of Stay: A Prospective Cohort Study
por: Thiara, Sonny, et al.
Publicado: (2022)

Hypernatremia and intracranial pressure: more questions than answers
por: Griesdale, Donald EG, et al.
Publicado: (2013)

Clinical pathophysiology of hypoxic ischemic brain injury after cardiac arrest: a “two-hit” model
por: Sekhon, Mypinder S., et al.
Publicado: (2017)

Long-term survival with sickle cell disease: a nationwide cohort study of Medicare and Medicaid beneficiaries
por: Jiao, Boshen, et al.
Publicado: (2023)

Spontaneous Pneumomediastinum in COVID-19: The Macklin Effect?
por: Sekhon, Mypinder S., et al.
Publicado: (2021)

Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma
por: Perry, C., et al.
Publicado: (2021)

Prognostic peripheral blood biomarkers at ICU admission predict COVID-19 clinical outcomes
por: Messing, Melina, et al.
Publicado: (2022)

Dasatinib and dexamethasone followed by hematopoietic cell transplantation for adults with Ph-positive ALL
por: Wieduwilt, Matthew J., et al.
Publicado: (2021)

Clinical targeting of the cerebral oxygen cascade to improve brain oxygenation in patients with hypoxic–ischaemic brain injury after cardiac arrest
por: Hoiland, Ryan L., et al.
Publicado: (2023)

Tandem high-dose influenza vaccination is associated with more durable serologic immunity in patients with plasma cell dyscrasias
por: Branagan, Andrew R., et al.
Publicado: (2021)

Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial
por: Daver, Naval G., et al.
Publicado: (2023)

Association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19
por: Tonon, David, et al.
Publicado: (2021)

Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma
por: Bartlett, Nancy L., et al.
Publicado: (2023)

Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
por: Vijenthira, Abi, et al.
Publicado: (2020)

Total marrow and lymphoid irradiation as conditioning in haploidentical transplant with posttransplant cyclophosphamide
por: Al Malki, Monzr M., et al.
Publicado: (2022)

Hypernatremia in patients with severe traumatic brain injury: a systematic review
por: Kolmodin, Leif, et al.
Publicado: (2013)

Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia
por: Muffly, Lori, et al.
Publicado: (2022)

Post hoc longitudinal assessment of the efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia B
por: Shapiro, Amy D., et al.
Publicado: (2023)

The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 study
por: Aldoss, Ibrahim, et al.
Publicado: (2022)

Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies
por: Tam, Constantine S., et al.
Publicado: (2022)

Idasanutlin plus cytarabine in relapsed or refractory acute myeloid leukemia: results of the MIRROS trial
por: Konopleva, Marina Y., et al.
Publicado: (2022)

Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study
por: Abel, Gregory A., et al.
Publicado: (2023)

Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε inhibitor, in relapsed/refractory lymphoid malignancies
por: Davids, Matthew S., et al.
Publicado: (2021)

Association of hemoglobin concentration and mortality in critically ill patients with severe traumatic brain injury
por: Sekhon, Mypinder S, et al.
Publicado: (2012)

Decreased parasite burden and altered host response in children with sickle cell anemia and severe anemia with malaria
por: Henrici, Ryan C., et al.
Publicado: (2021)

Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL: the HOVON-100 trial
por: Rijneveld, Anita W., et al.
Publicado: (2022)

Atezolizumab alone or in combination did not demonstrate a favorable risk-benefit profile in myelodysplastic syndrome
por: Gerds, Aaron T., et al.
Publicado: (2022)

Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCL
por: Martin, Peter, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_brban51j4o555siovtegoromuk